MindBio Therapeutics Corp C.MBIO

Healthcare Biotechnology

MindBio Therapeutics Corp. is a biotech/biopharma company. It creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. It is focused on microdosing of psychedelic medicines and is advancing its drug and technology protocols through clinical trials. It develops a multi-disciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase 1 clinical trials in 80 healthy participants and has completed a Phase 2a clinical trial in patients with Major Depressive Disorder. The underway are two Phase 2B trials, one in cancer patients experiencing existential distress and another in patients with Major Depressive Disorder. It invests in research that forms the basis for developing novel and clinically proven treatments.

CSE:MBIO - Post by User

MindBio Therapeutics Corp

<< Previous

Bullboard Posts

Next >>

Post by Dude51on Dec 08, 2023 1:49pm

95 Views

Post# 35775300

Just more BS trading! Look at the exchanges. were the

only exchange in the red? What a coincidence.

Trades for C:MBIO on 20231208 - 7 trades displayed

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
09:49:55	D	0.03	0.025	400	80 National Bank	7 TD Sec	E
09:50:56	D	0.03	0.025	75	7 TD Sec	7 TD Sec	E
10:37:49	D	0.03	0.025	28	80 National Bank	2 RBC	E
11:51:28	C	0.025		350	7 TD Sec	79 CIBC	E
12:07:26	D	0.03	0.025	25	80 National Bank	7 TD Sec	E
12:07:37	D	0.03	0.025	100	7 TD Sec	7 TD Sec	E
12:08:00	D	0.03	0.025	19	80 National Bank	2 RBC	E